SecBot SecBot
6-K ·Filed Sep 10, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001575872-26-000642
Actionable Insight • Neutral

This is a routine ESOP exercise with no trading implications. Monitor next quarterly filing for any changes in share count or material business developments.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$11.71
T+0 close · Sep 10, 2026 · via day close
Latest settled
+1.62%
T+1 · $11.90
Vs SPY
+0.77%
α at T+1
Next horizon
T+5
due 2mo ago
  1. T+0 · Sep 10 $11.71entry
  2. T+1 · 2mo ago +1.62%α +0.77% · $11.90
  3. T+5 · due 2mo ago Pending
  4. T+20 · due 6w ago Pending
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's filed a routine 6-K reporting the allotment of 375 equity shares upon exercise of stock options under its ADR Stock Option Scheme. This is a de minimis issuance representing approximately 0.00004% of total outstanding shares, with no material financial impact or strategic significance.

Key Facts

  • Allotted 375 equity shares of Re. 1 each on September 10, 2026
  • Issued under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
  • Exercise price was Re. 1 per share
  • Total issued shares after allotment: 83,46,81,285
  • Dilution is negligible at ~0.00004% of outstanding shares

Financial Impact

Negligible, 375 shares at Re. 1 par value, no premium. Total dilution is approximately 0.00004% of outstanding shares.

dilution

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
31% bullish (45 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (RDY), Batch item 10001575872-26-000642
Document: 0001575872-26-000642-index.html0001575872-26-000642
Document: 0001575872-26-000642.txt0001575872-26-000642
6-K Filing (RDY), Batch item 40001575872-26-000642
Document: 0001575872-26-000642-index.html0001575872-26-000642
Document: 0001575872-26-000642.txt0001575872-26-000642

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026